SGLT2 inhibitors for diabetes: turning symptoms into therapy

被引：12
|
作者：
Diamant, Michaela [1 ]
Morsink, Linde M. [1 ]
机构：
[1] Vrije Univ Amsterdam Med Ctr, Ctr Diabet, NL-1018 HZ Amsterdam, Netherlands
来源：
LANCET | 2013年 / 382卷 / 9896期
关键词：
GLUCOSE; HYPERGLYCEMIA; MELLITUS; KIDNEY;
D O I：
10.1016/S0140-6736(13)60902-2
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：917 / 918
页数：2
相关论文
共 50 条
  • [21] SGLT2 inhibitors
    Dardi, I.
    Kouvatsos, T.
    Jabbour, S. A.
    BIOCHEMICAL PHARMACOLOGY, 2016, 101 : 27 - 39
  • [22] Diabetes and gout: another role for SGLT2 inhibitors?
    Bailey, Clifford J.
    THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM, 2024, 15
  • [23] SGLT2 inhibitors
    Steyn, Lynda
    SA PHARMACEUTICAL JOURNAL, 2018, 85 (01) : 72 - 75
  • [24] Minireview: are SGLT2 inhibitors heart savers in diabetes?
    Rotkvic, Petra Grubic
    Berkovic, Maja Cigrovski
    Bulj, Nikola
    Rotkvic, Luka
    HEART FAILURE REVIEWS, 2020, 25 (06) : 899 - 905
  • [25] SGLT2 inhibitors in Type 1 diabetes: is this the future?
    Herring, R.
    Russell-Jones, D. L.
    DIABETIC MEDICINE, 2018, 35 (12) : 1642 - 1643
  • [26] Minireview: are SGLT2 inhibitors heart savers in diabetes?
    Petra Grubić Rotkvić
    Maja Cigrovski Berković
    Nikola Bulj
    Luka Rotkvić
    Heart Failure Reviews, 2020, 25 : 899 - 905
  • [27] Safety of SGLT2 Inhibitors in Patients with Diabetes Mellitus
    Singh, Mahakpreet
    Sharma, Ruchika
    Kumar, Anoop
    CURRENT DRUG SAFETY, 2019, 14 (02) : 87 - 93
  • [28] SGLT2 inhibitors enter crowded diabetes space
    Bouchie, Aaron
    NATURE BIOTECHNOLOGY, 2013, 31 (06) : 469 - 470
  • [29] SGLT2 inhibitors and the changing landscape for treatment of diabetes
    Liu, Shuangbo
    Lam, Anna
    Wazir, Arslan
    Cheema, Asim N.
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2019, 15 : 861 - 867
  • [30] SGLT2 inhibitors enter crowded diabetes space
    Aaron Bouchie
    Nature Biotechnology, 2013, 31 : 469 - 470
12345